326
- El Miedany Y. Patient reported outcome measures: from generic to specifi c. Clin Rheumatol.
2014;32:S40–6. - Bowman SJ, Booth DA, Platts RG, Field A, Rostron J, UK Sjögren’s Interest Group. Validation
of the Sicca symptoms Inventory for clinical studies of Sjögren’s syndrome. J Rheumatol.
2003;30:1259–66. - Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profi le.
Community Dent Health. 1994;11:3–11. - Iacopino AM. Relationship between periodontal disease and general health: role of infl amma-
tion. J Can Dent Assoc. 2008;74:695–6. - Locker D, Matear D, Stephens M, et al. Comparison of the GOHAI and OHIP-14 as measures
of the oral health related quality of life of the elderly. Community Dent Oral Epidemiol.
2001;29:373–81. - McMillan AS, Leung KC, Leung WK, et al. Impact of Sjogren’s syndrome on oral health-
related quality of life in southern Chinese. J Oral Rehabil. 2004;31:653–9. - Larsson P, List T, Lundstrom I, et al. Reliability and validity of a Swedish version of the Oral
Health Impact Profi le (OHIP-S). Acta Odontol Scand. 2004;62:147–52. - Allen PF, McMillan AS, Walshaw D, Locker D. A comparison of the validity of generic and
disease specifi c measures in the assessment of oral health related quality of life. Community
Dent Oral Epidemiol. 1999;27:344–52. - Schiffman RM, Christianson MD, Jacobsen G. Reliability and validity of the Ocular Surface
Disease Index. Arch Ophthalmol. 2000;118:615–21. - Vitale S, Goodman LA, Reed GF, Smith JA. Comparison of the NEI-VFQ and OSDI question-
naires in patients with Sjogren’s syndrome related dry eye. Health Qual Life Outcomes.
2004;2:44–9. - Dry eye workshop: the defi nition and classifi cation of dry eye disease: report of the Defi nition
and Classifi cation Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf.
2007; 5:75–92. - Goto E, Yagi Y, Matsumoto Y, Tsubota K. Impaired functional visual acuity of dry eye patients.
Am J Ophthalmol. 2002;133:181–6. - Friedman NJ. Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol.
2010;21:310–6. - Mertzanis P, Abetz L, Rajagopalan K, Espindle D, Chalmers R, Snyder C, Caffery B, Edrington
T, Simpson T, Nelson JD, et al. The relative burden of dry eye in patients’ lives: comparisons
to a U.S. normative sample. Invest Ophthalmol Vis Sci. 2005;46:46–50. - Nichols KK, Mitchell GL, Zadnik K. Performance and repeatability of the NEI-VFQ-25 in
patients with dry eye. Cornea. 2002;21:578–83. - Begley CG, Chalmers RL, Abetz L, Venkataraman K, Mertzanis P, Caffery BA, Snyder C,
Edrington T, Nelson D, Simpson T. The relationship between habitual patient-reported symp-
toms and clinical signs among patients with dry eye of varying severity. Invest Ophthalmol Vis
Sci. 2003;44:4753–61. - McCarty CA, Bansal AK, Livingston PM, Stanislavsky YL, Taylor HR. The epidemiology of
dry eye in Melbourne, Australia. Ophthalmology. 1998;105:1114–9. - McMonnies CW. Key questions in a dry eye history. J Am Optom Assoc. 1986;57:512–7.
- Schein OD, Munoz B, Tielsch JM, Bandeen-Roche K, West S. Prevalence of dry eye among
the elderly. Am J Ophthalmol. 1997;124:723–8. - Guillemin I, Begley C, Chalmers R, et al. Appraisal of patient-reported outcome instruments
available for randomized clinical trials in dry eye: revisiting the standards. Ocul Surf.
2012;10:84–99. - Chalmers RL, Begley CG, Edrington T, Caffery B, Nelson D, Snyder C, Simpson T. The agree-
ment between self-assessment and clinician assessment of dry eye severity. Cornea.
2005;24:804–10. - Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, Pepose JS,
Kosheleff V, Porreco A, Lemp MA. An objective approach to dry eye disease severity. Invest
Ophthalmol Vis Sci. 2010;51:6125–30.
M.O. Hegazi et al.